Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential Mechanisms

UNC Libraries(2021)10.17615/5h4x-0k36Source: DataRank Database

Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential Mechanisms is a research paper published in UNC Libraries (2021). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.00)OA: greenTopics (17)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Ethan J. Fritch ORCID,Brett L. Hurst ORCID,Peter B. Madrid ORCID,Carolina Horta Andrade ORCID,Thomas R. Lane ORCID

Live enrichment

PubMed:19965766 OpenAlex:https://openalex.org/W4287445057

National Institutes of Health

Grant: 5R01AI108197-10

Determinants of Coronavirus Fidelity in Replication and Pathogenesis

National Institutes of Health

Grant: 2R44GM122196-04A1

Centralized assay datasets for modelling support of small drug discovery organizations

National Institutes of Health

Grant: 1R43AT010585-01

MegaPredict for predicting natural product uses and their drug interactions

National Institutes of Health

Grant: 5U19AI142759-04

Antiviral Drug Discovery and Development Center (AD3C)

FWCI

0.00

Citation Percentile

0.2%

greenLicense: CC BY NC ND

repositoryhttps://doi.org/10.17615/5h4x-0k36

https://doi.org/10.1021/acsomega.0c05996

https://pubs.acs.org/doi/pdf/10.1021/acsomega.0c05996

https://dx.doi.org/10.17615/5h4x-0k36

https://pubmed.ncbi.nlm.nih.gov/33778258

Fields of Study

Viral Infections and Outbreaks ResearchHepatitis B Virus StudiesDisaster Response and Management0301 basic medicine03 medical and health sciences

Keywords

Marburg virusRepurposingVirologyEbola virusDrug repositioningEbolavirusPharmacologyBiologyVirusDrugChemistryQD1-999

Sustainable Development Goals

SDG 3: 3. Good health